Long-term follow-up using 18F-FDG PET/CT for postoperative olfactory neuroblastoma
Authors:
- Akira ToriiharaATAkira Toriihara
- Kazunori KubotaKKKazunori Kubota
- Youichi MachidaYMYouichi Machida
- Shin NakamuraSNShin Nakamura
- Seiji KishimotoSKSeiji Kishimoto
- Isamu OhashiIOIsamu Ohashi
- Hitoshi ShibuyaHSHitoshi Shibuya
- 1 August 2014
- journal article
- Published by Wolters Kluwer Health in Nuclear Medicine Communications
- Vol. 35 (8) , 857-863
Abstract
The present study evaluated the usefulness of postoperative fluorine-18 fluorodeoxyglucose (F-FDG) PET/computed tomography (CT) in the management of olfactory neuroblastoma (ONB). Ten patients (eight men and two women; mean age, 48.5 years) with histologically confirmed ONB who underwent craniofacial resection were retrospectively included in this study. A total of 42 whole-body F-FDG PET/CT scans for postoperative surveillance or restaging were reviewed. The mean time from operation until the PET/CT scan was 42.1 months. We evaluated the F-FDG uptake and the presence of recurrent lesions during the follow-up period and compared the PET/CT results with the results of MRI and clinical examination (endoscopy). Seven of the 10 patients had 24 recurrent lesions, and 18 of these recurrent lesions (seven local recurrences, eight cervical lymph node metastases, one intracranial metastasis, and two distant metastases) were F-FDG positive (75.0%). Three local recurrences and three intracranial metastases were false negative and were detected by endoscopy and MRI, respectively. The mean time from operation until recurrence was 51.4 months, and 17 lesions (70.8%) occurred more than 2 years after the initial operation. Although F-FDG PET/CT is useful for the detection of postoperative recurrences of ONB, long-term follow-up combined with endoscopy and MRI is mandatory.Keywords
This publication has 11 references indexed in Scilit:
- Stereotactic Radiosurgical Salvage Treatment for Locally Recurrent EsthesioneuroblastomaNeurosurgery, 2013
- The Added Value of 18F-FDG PET/CT for Evaluation of Patients with EsthesioneuroblastomaJournal of Nuclear Medicine, 2012
- F-18 FDG and C-11 Methionine PET/CT in Intracranial Dural MetastasesClinical Nuclear Medicine, 2012
- Preliminary Study on the Evaluation of Olfactory Neuroblastoma Using PET/CTClinical Nuclear Medicine, 2011
- Long‐term results of 28 esthesioneuroblastomas managed over 35 yearsHead & Neck, 2011
- Salvage Treatment of Local Recurrence in Esthesioneuroblastoma: A Meta-analysisJournal of Neurological Surgery Part B: Skull Base, 2010
- Olfactory NeuroblastomaHead and Neck Pathology, 2009
- EsthesioneuroblastomaJAMA Otolaryngology–Head & Neck Surgery, 2006
- Esthesioneuroblastoma: a Danish Demographic Study of 40 Patients Registered Between 1978 and 2000Acta Oto-Laryngologica, 2003
- Esthesioneuroblastoma: a meta-analysis and reviewThe Lancet Oncology, 2001